SomnoMed Stock Forecast for 2023 - 2025 - 2030

Updated on 05/07/2024

Stock Rating
10
Price Target
$0.23
Consensus
Neutral
Upside
15.00%
Analysts
0
Stock Rating
10
Upside
15.00%
Analysts
0
Price Target
$0.23

SomnoMed Stock Forecast and Price Target

Given the average yearlong price target of $0.23 provided by prominent analysts over the past few months, there is a potential upside of approximately 15% from the last closing price in May, 2024 for SomnoMed's stock if it is reached. This estimation is based on a high estimate of $0.23 and a low estimate of $0.23. Even if you're not interested in SOM stock, you may be interested in its competitors.

$0.23

15.00% Upside

Hold
Hold

SomnoMed Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, SomnoMed's Price has seen an increase, rising from $0.00 to $0.00. This represents a growth of 100.00%. Analysts predict that SomnoMed's Fair Value will increase in the upcoming year, reaching $0.20. This would represent an increase of 100.00%. Over the next seven years, experts predict that SomnoMed's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$0.20
2025 Fair Value Forecast
$0.22
2026 Fair Value Forecast
$0.24
2027 Fair Value Forecast
$0.27
2028 Fair Value Forecast
$0.29
2029 Fair Value Forecast
$0.32
2030 Fair Value Forecast
$0.35

SomnoMed Revenue Forecast for 2023 - 2025 - 2030

In the last three years, SomnoMed's Revenue has seen an increase, rising from $57.30M to $83.62M. This represents a growth of 45.93%. Analysts predict that SomnoMed's Revenue will increase in the upcoming year, reaching $92.59M. This would represent an increase of 10.73%. Over the next seven years, experts predict that SomnoMed's Revenue will grow at a rate of 28.03%.

2024 Rev Forecast
$0.09B
2025 Rev Forecast
$0.10B
2026 Rev Forecast
$0.12B
2027 Rev Forecast
$0.10B
2028 Rev Forecast
$0.10B
2029 Rev Forecast
$0.10B
2030 Rev Forecast
$0.11B

SomnoMed Dividend per Share Forecast for 2023 - 2025 - 2030

2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00

SomnoMed Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$-4300000.00
2025 FCF Forecast
$-100000.00
2026 FCF Forecast
$-4300000.00
2027 FCF Forecast
$-61700126.67
2028 FCF Forecast
$-886281186.15
2029 FCF Forecast
$-48036440.29
2030 FCF Forecast
$-297657802.25

SomnoMed EBITDA Forecast for 2023 - 2025 - 2030

SomnoMed's EBITDA has decreased by 916.67% In the last three years, from $300.00k to $-2.45M. In the following year, the 1 analysts surveyed believe that SomnoMed's EBITDA will decrease by 235.51%, reaching $3.32M. According to professionals, by 2030, SomnoMed's EBITDA will have decreased by 825.12%, falling down to $17.77M.

2024 EBITDA Forecast
$0.00B
2025 EBITDA Forecast
$0.01B
2026 EBITDA Forecast
$0.01B
2027 EBITDA Forecast
$0.00B
2028 EBITDA Forecast
$0.00B
2029 EBITDA Forecast
$0.01B
2030 EBITDA Forecast
$0.02B

SomnoMed EBIT Forecast for 2023 - 2025 - 2030

In the last three years, SomnoMed's EBIT has increased by 332.98%, going from $-940.00k to $-4.07M. The next year, 1 experts forecast that SomnoMed's EBIT will decrease by 50.12%, reaching $-2.03M. In 2030, professionals predict that SomnoMed's EBIT will decrease by 286.09%, reaching $7.57M.

2024 EBIT Forecast
$-2030000.00
2025 EBIT Forecast
$310.00k
2026 EBIT Forecast
$0.00B
2027 EBIT Forecast
$0.01B
2028 EBIT Forecast
$0.01B
2029 EBIT Forecast
$0.01B
2030 EBIT Forecast
$0.01B

SomnoMed EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, SomnoMed's EPS has seen an increase, rising from $-0.01 to $0.00. This represents a growth of 100.00%. Analysts predict that SomnoMed's EPS will increase in the upcoming year, reaching $-0.04. This would represent an increase of 100.00%. Over the next seven years, experts predict that SomnoMed's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$-0.04
2025 EPS Forecast
$-0.01
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00